| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Dec 22, 2025 | Immunome Inc. | CEO | Buy | 22.5 | -192,722 | -22.59% | ✗ | $149.1K |
| Dec 18, 2025 | Dec 18, 2025 | Immunome Inc. | CEO | Buy | 92.5 | +46,511 | 5.77% | ✗ | $1000K |
| Mar 26, 2025 | Mar 26, 2025 | Immunome Inc. | CEO | Buy | 97.5 | +137,100 | 20.47% | ✗ | $999.5K |
| Jan 31, 2025 | Feb 3, 2025 | Immunome Inc. | CEO | Buy | 100.0 | +150,000 | 28.87% | ✗ | $1.2M |
| Nov 21, 2024 | Nov 25, 2024 | Immunome Inc. | CEO | Buy | 97.5 | +100,000 | 23.83% | ✗ | $962.2K |
| May 20, 2024 | May 21, 2024 | Immunome Inc. | CEO | Buy | 100.0 | +100,000 | 31.29% | ✗ | $1.4M |
| Oct 2, 2023 | Oct 4, 2023 | Immunome Inc. | CEO | Buy | 97.5 | +169,204 | 112.48% | ✗ | $1000K |
| Aug 7, 2020 | Aug 11, 2020 | Ultragenyx Pharmaceutical Inc. | Director | Sell | 17.5 | -34,750 | -66.63% | ✗ | $3M |